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Abstract— Microfluidics based systems could be useful for 
drug discovery as they allow for miniaturization and could 
potentially be run as multiple parallel cell based assays.  Such 
miniaturization allows assays at single cell level and reduces 
the amount of test material needed, which, in the case of 
natural product extracts, simplifies the preparation.  Thyme 
species extracts have been reported to show some promising 
anti-cancer effects. In the present work, we used a 
microfluidics based system to study the effects of Thymus 
kotschyanusm Boiss plant extract on two human breast cancer 
cells lines which are MDA-MB-231 and MCF-7. For better 
understanding a single cancer cell death mechanism and a flow 
control, a Polydimethylsiloxane (PDMS) microfluidic device 
has been fabricated. The morphology of single cancer cells in 
the microfluidic system showed that the higher concentration 
of plant Thymus extract (560 µg/ml) had a significant effect on 
the cell membrane compared to the lower concentration (15 
µg/ml). In addition, the results showed that MDA-MB-231 cells 
were more sensitive to the cytotoxic effects of the extracts 
compared to the MCF-7 cells. These results concur with the 
MTT assay analysis that showed the IC50 values of the extract 
in MDA-MB-231 and MCF-7 cells to be 15 µg/ml and 60 µg/ml, 
respectively. This proof-of-principle study suggests the 
possibility of the use of microfluidics systems for natural 
product research. These systems could allow the development 
of miniaturized multiple parallel cell based assays which are 
measured with sensors and used for natural product drug 
discovery consistent with the needs of Industry 4.0.     
Keywords— Thymus; breast cancer cell; MTT assay; 
microfluidic. 
I. INTRODUCTION 
Breast cancer is cancer that develops from breast tissue 
and the second leading cause of deaths in women [1]. 
Nowadays, several studies have been reported for breast 
cancer treatment such as chemotherapy, however this 
method, suffer a high percentage of healthy cells will be lost 
with cancer cells due to non-selectivity of medicines [2]. 
Recently, it seems that there is an urgent need for 
improvements in detection, diagnosis, and treatment of breast 
cancer. Currently, in cancer prevention and treatment, 
several groups are found the natural products are play major 
role for drug discovery [3-5]. The natural compound used in 
medicine was produce by plants as the main source. Thymus 
genus belongs to Lamiaceae family which some species 
extracts of it have remarkably been demonstrated to 
positively affect depression and cancer cells [6-8]. One of the 
species which is widely grown in Iran, is T. kotschyanusm 
Boiss [9].  
Previous phytochemical analysis of Thymus species has 
confirmed the occurrence of phenolic compounds such as 
including carvacrol, thymol, p-cymene, and ɣ- terpinene [10, 
11]. It has been shown to exhibit a range of biological 
activities such as antibacterial, antifungal, insecticidal, 
analgesic and antioxidant properties [12-14]. Other groups 
applying a different method to demonstrate antioxidant 
properties of oil and volatile extracts from Thyme [15]. 
However, minor alteration in cellular conditions may 
significantly influence the cell properties. For that reason, a 
faithfully explore the cellular response to the tested drug 
conditions in a quantitative format, a steadier and more 
quantifiable environment is essentially required [16]. 
    Recently, microfluidics has shown a potential to become 
for real-time single cell analysis and repeatable media 
exchange [17]. The advance of microfluidic systems offers 
the possibility of measuring the real-time monitoring of 
individual cells [18]. Indeed, microfluidic based cell culture 
platform can mimic in vivo conditions as well as generate 
different environmental profiles. In addition, the microfluidic 
has capability to controlled precisely drug flow through 
inside culture chamber. Thus, it allows to monitor the cell’s 
response to high concentrations of drug inside the culture 
chamber [19,20]. The progress of microfluidic technology 
has demonstrated the capability to capture a single cell by 
channel geometry and controlling the fluid flow. 
     In this research, the effect of Thymus plant extracts on a 
single breast cancer cell morphology has been investigated 
through an inverted microscope and Real-Time Monitoring 
in a microfluidic device. The fabricated device provides a 
trapping site that allows for manipulation of cancer cells 
using the fluid control by syringe pump. Two type of breast 
epithelial cell lines included MDA-MB-231 and MCF-7 
were investigated. Alternatively, a fluorescence microscopy 
nuclear morphology assay and MTT assay were used to 
investigate the viability of two breast cancer cell lines. 
2018 IEEE-EMBS Conference on Biomedical Engineering and Sciences (IECBES)
978-1-5386-2471-5 ©2018 IEEE 647
Authorized licensed use limited to: UNIVERSITY TEKNOLOGI MALAYSIA. Downloaded on December 13,2020 at 04:14:11 UTC from IEEE Xplore.  Restrictions apply. 
II. MATERIALS AND METHODS 
A. Cell culture 
MDA-MB-231 and MCF-7 cell line was cultured in 
DMEM medium (Dulbecco’s Modified Eagle Medium) 
(Gibco® Life Technologies, NY, USA) containing 10% 
heat-deactivated Fetal Bovine Serum (Gibco® Life 
Technologies, USA) and 1x of Antibiotic/Antimycotic 
(Gibco® Life Technologies, USA). 
MCF-10A cell line was cultured in DMEM/F12 medium 
(Invitrogen, CA, USA) containing 5% of Horse Serum 
(Invitrogen, CA, USA) and 1x of Antibiotic/Antimycotic. 
This media was supplemented by 10ng/ml of Epidermal 
Growth Factor (Gibco® Life Technologies, NY, USA), 1x 
of Insulin Transferrin Selenium-A (ITS-A) (Gibco® 
Thermofisher Scientific, USA) and 0.5ug/ml of 
Hydrocortisone (STEMCELL™ Technologies, Vancouver, 
Canada). 
All cell lines were cultured in 10cm TPP plate (Merck 
KGaA, Darmstadt, Germany) and maintained at 37 °C and 
5% CO2 incubator. The growth of the cell was monitored 
every 2-3 days and media were changed every 3-4 days. 
Once the cells are 80-90% confluent, cells were trypsinized 
using TrypLE Express (Gibco® Thermofisher Scientific, 
USA) for 10 minutes. 
 
B. MTT assay 
MTT assay method was used to evaluate the cytotoxicity 
of the extract on MDA-MB-231 and MCF-7 cells as well as 
MCF-10A. The method is according to the ability of viable 
cells to produce purple formazan crystals from yellow 
tetrazolium salt MTT by the mitochondrial dehydrogenase. 
The cells were plated into 96-well plate (Nunc, Denmark) at 
a density of 104 cells/well/200 µl [21]. After 24h, a fresh 
complete medium containing different extract 
concentrations (16, 60, 120, 560 µg/ml) and 0.2% DMSO 
(Sigma, USA) as a negative control were replaced.  
 
 
Fig. 1. The schematic of microfluidic device 
Next, 10 ml of MTT labeling reagent was dispensed into 
each well, then the cells were administered with the extract 
for 24 h. The plates were incubated at 37 ºC and 5% CO2 for 
4 h. Afterward, supernatants were discarded and 100 ml of 
the solubilization solution was added to each well and plates 
were incubated overnight in a humidity atmosphere [21]. 
Finally, cytotoxicity was detected by measuring the 
absorbance at a wavelength of 570 nm using an ELISA plate 
reader (Lab System).  
 
C. T. Kotschyanusm boiss extract preparation 
      T. kotschyanusm Boiss were obtained from Iran. They 
harvested from Thymus plant and rinsed with deionized 
water multiple times for removing dust, then left to dry for 
15 days in room temperature and in the shadow. The 
desiccated Thymus was grinded and boiled for 10 minutes 
and was filtrated. Thereafter, the extract was centrifuged at 
1200 RPMs for 5 minutes for separating heavy biomaterial 
within the extract. The resulting solution was filtrated with 
filter paper. Finally, the solution was condensed using rotary 
equipment down to 5 ml. The extract was then dispersed in 
thin films on glass plates which later dried in a temperature 
below 45 °C. Through weighing the plates once empty and 
once after the desiccation of the extract, the amount of the 
yielded extract was found. The extraction efficiency was 
obtained by dividing the yielded weight by the sample 
weight. After that, the extract was kept in the refrigerator 
until the time of the experiment. 
 
D. Microfluidic fabrication  
The standard soft lithography technique was utilized to  
fabricate the PDMS microchip [22]. The fabrication process 
consisted of mould fabrication and PDMS casting. The 
design was patterned using chrome mask on a silicon wafer 
substrate coated by SU-8 photoresist (MicroChem 3025, 
USA). These designs defined the dimensions of the micro-
channels and inlet/outlet. The schematic and dimensions of 
the features are given in Fig. 1. PDMS (Sylgard 184A, 
USA) was poured onto SU-8 master mold after mixing with 
a curing agent (SYLGARD 184B, USA) in a ratio of 10:1 
by weight.  After curing at 80 °C for 2 h, the PDMS was 
peeled off from the master mold [23]. Then, the PDMS was 
permanent bonding onto a glass slide to form a closed 
channel after washing with Isopropanol and treated by 
Oxygen plasma (Plasma Etch PE-25) for 25 seconds 
[24,25]. A microfluidic funnel shaped channel was designed 
and fabricated in order to investigate the reaction of a single 
cancer cell in the microchannel [26].  
 
E. Cell culture in microfuidic device 
Before experiments, the microfluidic devices were 
sterilized using 70% weight ethanol aqueous solution for 30 
minutes and sequentially replaced the ethanol solution by 
30% weight ethanol and PBS aqueous solution to prevent 
bubble trapping in the channels. The PDMS device was 
sterilized under UV light for 15 minutes. The cells were 
passaged with standard 0.25% weight trypsin solution 
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(Gibco, Invitrogen), which was neutralized by a medium. 
The cell suspension solution was centrifuged at 1,500 rpm 
for 5 min and the cells were resuspended in cell culture 
medium. The cells were diluted to a density of 2 × 106 
cells/mL after counting the cell number by using 
hemocytometer. Then the cell was infused into the 
microchannel by utilized a syringe pump for further culture. 
 
III. RESULTS AND DISCUSSIONS 
A. Elemental compositions 
Fig. 2 shows the field-emission scanning electron 
microscopy (FESEM) image of the herb extract sample. Fig. 
3 illustrates the Energy-dispersive X-ray spectroscopy 
(EDX), which determines the elemental compositions and 
spatial distributions of existent elements in the herb extract 
sample. The observed characteristics peaks in Fig. 3 
confirmed the existence of chlorine with an atomic weight 
of 17.98%, 59.05% of oxygen, 1.04% of Magnesium, 0.61% 
of Phosphorus, 1% of Calcium and 20.28% of Potassium in 
the extracted sample. The EDX spectrum of element 
analysis was tabulated in Table 1. In addition, the EDX 
mapping analysis illustrates the uniform dispersion of all 
elements across the sample. Carl Zeiss Ultra 55 FE-SEM 








TABLE 1: THE EDX SPECTRUM OF ELEMENT ANALYSIS 
Element Weight (%) Atomic (%) 
O 38.43 59.09 
Mg 1.03 1.04 
P 0.77 0.61 
Cl 25.91 17.98 
K 32.23 20.28 
Ca 1.64 1.00 
Total 100.00 100.00 
  
 
Fig. 3. EDX pattern and mapping analysis of the herb extract
 
B.          Cell viability determination by MTT assay 
The viability of cells was determined by MTT assay as 
described in section II (B). The cytotoxicity of the extract 
was evaluated on both cancer cells MCF-7 and MDA-MB-
231 as well as MCF-10A cells by using the MTT method. 
The cells were treated with different concentrations (15-560 
µg/ml) of extract for 24 h and then MTT assay was used to 
measure mitochondrial activity inviable cells. Fig. 4 shows 
that the Thymus extract could decrease cell viability in a 
dose dependent manner in both cancer cells. However, 
cytotoxicity of extract in MCF-7 was lower than MDA-MB-
231. 
The IC50 values of the extract in MDA-MB-231 and 
MCF-7 cells were found to be 15 µg/ml and 60 µg/ml, 
respectively. Because the IC50 value of Thymus extract in 
MDA-MB-231 cells are lower than MCF-7 cells, indicating 
that these cells are more sensitive to cytotoxic effects of the 
extract. In addition, cell viability assay shows that thymus 
extracts are nearly nontoxic for normal MCF-10A cells. 
Even at higher concentrations of extract (560 µg ml-1), cells 
are viable, and the results are statistically significant 
(p<0.05).  
 
C. Morphological analysis of an elongated single 
cancer cell in microfluidic device 
      The attached MDA-MB-231 cells and MCF-7 cells were 
injected into the microchannel with a syringe pump for 
analyzing a single cancer cell. The few cells were trapped 
inside an aggregation microchannel by controlling the fluid 
flow. Firstly, the flow rate was 0.05 µL/min and then it was 
stopped. In this condition, the cell flow can be controlled 
and reduced to attach the cell in the desired area in the 
microfluidic devices. In fact, by controlling the flow rate 
and microchannel shape, the few numbers of cells are 
trapped in a microfluidic system (Fig. 5a). The first attached 
cells are treated as an obstacle, which reduces the flow rate 
and attaching more cells. After 2 days culturing, cells are 
appeared thin and elongated after 24h culture in the 
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Fig. 4. Cell viability in treated cells versus untreated cells 
 
 
microfluidic device inside an incubator.  
       MCF-7 has a cobblestone-like phenotype with strong 
cell-cell adhesion, whereas MDA-231 cells have an 
elongated fibroblast-like morphology and pronounced 
cellular scattering (Fig. 5b and c). The extract fluid was then 
infused into microfluidic channels then the reaction effect 
on the cancer cells was observed after 3h. Fig. 6 shows the 
optical microscopic images of cancer cells while treated 
during 3h with high (560 µg/ml) and low concentration (15 
µg/ml) of extract. Both cell death mechanisms, though very 
different, can be observed and differentiated with extract 
concentration. Cell death mechanism is different for two 
cases of high and low concentration of the extract, as shown 
in Fig. 6. It is usually expected that very high toxic 
concentration of cytotoxic can induce a massive "physical" 
damage to most cell components including cell membranes 











However, at low concentration of extract can cause the 
apoptotic on cells (Fig. 6b and d) [27]. Also, the 
morphology changes of MDA-MB-231 cancer cells are 
during 3h and for MCF-7 cells are during 6 h. In addition, 
MDA-MB-231 cells demonstrated to be more sensitive than 
MCF-7 cells, because of greater inhibitory effect in MDA-







Fig. 6: Morphology changes in elongated MDA-MB-231 cancer cells after 
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IV. CONCLUSION 
 
This study investigated the anti-cancer activity of Thymus 
Kotschyanusm Boiss plant extract on breast cancer line 
(MDA-MB-231 and MCF-7). The results showed that the 
high concentration of thymus (560 µg/ml) has more effect 
on the cell membrane and has less effect for low 
concentration case (15 µg/ml). The results were completely 
in agreement with MTT assay analysis. In addition, the 
results demonstrated that the MDA-MB-231 cells are more 
sensitive to extract compared with MCF-7 cancer cell lines. 
In conclusion, the achieved results in this research are 
significant for breast cancer treatment since in 
chemotherapy method, a high percentage of healthy cells 
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